This case reports on a 53-year-old male patient with primary refractory high-grade B-cell lymphoma, who was hospitalized to undergo Chimeric Antigen Receptor (CAR) T-cell therapy. [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/07/CoW_33_2021_E_web_compressed.pdf"]
Read More
Abstract Purpose of review To review pathophysiological pathways of immune system response to infections, which may justify mediators removal by extracorporeal blood purification therapies (EBPTs) in critically ill septic patients...
Read More